Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Barriers to preventive intervention.

Gloria M Petersen1

  • 1Department of Health Sciences Research, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA. peterg@mayo.edu

Gastroenterology Clinics of North America
|December 20, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Discovery and Validation of Methylated DNA Markers From Pancreatic Neuroendocrine Tumors.

Gastro hep advances·2024
Same author

Polycyclic Aromatic Hydrocarbons and Pancreatic Cancer: An Analysis of the Blood Biomarker, <i>r</i>-1,<i>t</i>-2,3,<i>c</i>-4-Tetrahydroxy-1,2,3,4-tetrahydrophenanthrene and Selected Metabolism Gene SNPs.

Nutrients·2024
Same author

A Randomized Trial of Two Remote Health Care Delivery Models on the Uptake of Genetic Testing and Impact on Patient-Reported Psychological Outcomes in Families With Pancreatic Cancer: The Genetic Education, Risk Assessment, and Testing (GENERATE) Study.

Gastroenterology·2024
Same author

Risk of Syndrome-Associated Cancers Among First-Degree Relatives of Patients With Pancreatic Ductal Adenocarcinoma With Pathogenic or Likely Pathogenic Germline Variants.

JAMA oncology·2023
Same author

Culture media composition influences patient-derived organoid ability to predict therapeutic responses in gastrointestinal cancers.

JCI insight·2022
Same author

Tissue methylated DNA markers for sporadic pancreatic cancer are strongly associated with familial and genetically predisposed pancreatic cancer.

Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.]·2022
Same journal

Living Donor Intestinal and Liver Transplantation.

Gastroenterology clinics of North America·2026
Same journal

Living Abdominal Organ Donation: A Plan B That Saves Lives.

Gastroenterology clinics of North America·2026
Same journal

Long-Term Outcomes of Living Liver Donors.

Gastroenterology clinics of North America·2026
Same journal

Perioperative Management of Living Liver Donor Patients.

Gastroenterology clinics of North America·2026
Same journal

Living Donor Liver Transplantation for Colorectal Cancer Liver Metastasis.

Gastroenterology clinics of North America·2026
Same journal

Living Donor Liver Graft in Adult Populations: Donor Selection and Workup.

Gastroenterology clinics of North America·2026
See all related articles

Barriers to colorectal cancer screening adherence exist, stemming from patient knowledge, perceived risk, and provider recommendation. Addressing these intrinsic and extrinsic factors is crucial for improving screening rates.

Area of Science:

  • Oncology
  • Public Health
  • Health Services Research

Background:

  • Colorectal cancer screening is vital for early detection and improved patient outcomes.
  • Numerous studies have investigated factors influencing adherence to screening recommendations.
  • A comprehensive understanding of barriers remains incomplete, hindering effective intervention strategies.

Purpose of the Study:

  • To synthesize findings from colorectal cancer screening studies regarding adherence barriers.
  • To identify consistent patterns and categories of barriers to screening.
  • To highlight the need for interventions addressing identified barriers.

Main Methods:

  • Systematic review and synthesis of existing colorectal cancer screening adherence studies.

Related Experiment Videos

  • Categorization of identified barriers into intrinsic and extrinsic factors.
  • Analysis of emerging patterns in screening adherence data.

    • Main Results:

    • Barriers to colorectal cancer screening adherence are multifactorial, encompassing intrinsic and extrinsic elements.
    • Intrinsic barriers include demographic, medical, psychological, and knowledge/attitude/belief factors.
    • Extrinsic barriers involve healthcare access, provider factors, and lifestyle issues.
    • Lower adherence is associated with decreased patient knowledge, lower perceived risk, and lack of provider recommendation.

    Conclusions:

    • Definitive conclusions on all barriers are not yet established.
    • Consistent patterns indicate that patient-level factors and healthcare provider engagement significantly impact screening adherence.
    • Development of targeted interventions is necessary to overcome identified barriers and enhance colorectal cancer screening rates.